Jinyu Bio-technology , Ltd. Profit Margin

As of the most recent data (September 2026), 600201.SS shows a profit margin of 10.27%. That compares with 7.59% in the prior-year period — up 35.3% year over year. That is below the Healthcare sector average of 19.13%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 600201.SS's profit margin is now 10.27% (was 7.59%) — a 35.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Jinyu Bio-technology , Ltd. is outperforming or lagging.

The Healthcare sector average profit margin is about 19.13%. Jinyu Bio-technology , Ltd. is at 10.27%, which is lower that average. That is roughly 46.3% below the sector mean. Use the comparison chart on this page to see how 600201.SS stacks up against individual peers as well.

That compares with 7.59% in the prior-year period — up 35.3% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Jinyu Bio-technology , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Jinyu Bio-technology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 10.27%) with ownership activity and broader fundamentals.